| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/30/2013 | US8431398 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 04/30/2013 | US8431397 Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair |
| 04/30/2013 | US8431396 Anti-angiogenic peptides |
| 04/30/2013 | US8431395 Pluripotent cells from rat and other species |
| 04/30/2013 | US8431394 Antibody or fragment thereof recognizing Avitag™ and uses thereof |
| 04/30/2013 | US8431393 AIMP2-DX2 gene and its uses |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431375 Method for marking materials |
| 04/30/2013 | US8431365 β1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 04/30/2013 | US8431355 Process for screening glycoform-specific antibodies |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431350 Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide |
| 04/30/2013 | US8431349 Compositions and methods for early pregnancy diagnosis |
| 04/30/2013 | US8431162 Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor |
| 04/30/2013 | US8431130 IL-18 binding proteins |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | CA2806666A1 Maize inbred phppe |
| 04/30/2013 | CA2806605A1 Variety corn line ff5130 |
| 04/30/2013 | CA2806590A1 Canola variety 43e02 |
| 04/30/2013 | CA2806581A1 Variety corn line aa2205 |
| 04/30/2013 | CA2806579A1 Maize inbred ph1kr5 |
| 04/30/2013 | CA2575388C Methods and compositions for modulating flowering and maturity in plants |
| 04/30/2013 | CA2568935C Inactive ca2+/calmodulin-dependent protein kinase ii.alpha. knockin animal and knockin cell of the same |
| 04/30/2013 | CA2523417C Method for storing tumor cells |
| 04/30/2013 | CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 04/30/2013 | CA2453522C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/30/2013 | CA2416633C Enhanced replication of hcv rna |
| 04/30/2013 | CA2403964C Compositions and methods for dendritic cell-based immunotherapy |
| 04/30/2013 | CA2257068C Isolation, propagation, and directed differentiation of stem cells from central nervous system of mammals |
| 04/25/2013 | WO2013059829A1 Method and composition for inducing human pluripotent stem cells |
| 04/25/2013 | WO2013059755A1 Layered microfluidic living cell array |
| 04/25/2013 | WO2013059754A1 Continuous flocculation deflocculation process for efficient harvesting of microalgae from aqueous solutions |
| 04/25/2013 | WO2013059644A1 Method to measure inflammation in the conjunctiva of patients with tear dysfunction |
| 04/25/2013 | WO2013059593A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | WO2013059373A2 Media for stem cell proliferation and induction |
| 04/25/2013 | WO2013059357A1 Methods, kits, and compositions for stem cell self-renewal |
| 04/25/2013 | WO2013059264A1 Embryonic stem cell models |
| 04/25/2013 | WO2013058578A2 System for screening skin-whitening material |
| 04/25/2013 | WO2013058537A2 Living fatty material from which immunity is removed and method for manufacturing same |
| 04/25/2013 | WO2013058403A1 Method for culturing pluripotency-maintained singly dispersed cells by means of laminar flow |
| 04/25/2013 | WO2013058388A1 Anti-gap43 antibody |
| 04/25/2013 | WO2013057681A1 Drought-tolerant transgenic plants comprising decreased myc4 activity and methods for their use |
| 04/25/2013 | WO2013057628A1 Addition of iron to improve cell culture |
| 04/25/2013 | WO2013057513A2 Therapeutic compositions and uses |
| 04/25/2013 | WO2013057357A1 Method for identifying drugs of use in the treatment of cardiovascular diseases |
| 04/25/2013 | WO2013057164A1 Production of a human beta cell line from an early post natal pancreas |
| 04/25/2013 | WO2013056677A1 USE OF OsPP18 GENE IN CONTROLLING RICE DROUGHT RESISTANCE |
| 04/25/2013 | WO2013056657A1 Activity-enhanced l-asparaginase variant |
| 04/25/2013 | WO2013056535A1 Method for increasing efficiency of generating inducted pluripotent stem cell |
| 04/25/2013 | WO2013032158A3 Method for inducing stem-cells to differentiate into muscle cells |
| 04/25/2013 | WO2012170431A3 Improved geneswitch systems |
| 04/25/2013 | WO2012021814A3 Methods for making a tissue engineered muscle repair (temr) construct in vitro for implantation in vivo |
| 04/25/2013 | WO2011116954A3 Prophylaxis of colorectal and gastrointestinal cancer |
| 04/25/2013 | US20130104253 Cytoplasmic transfer to de-differentiate recipient cells |
| 04/25/2013 | US20130103151 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 04/25/2013 | US20130102838 Oocyte Spindle-Associated Factors Improve Somatic Cell Cloning |
| 04/25/2013 | US20130102769 Interfering rna molecules |
| 04/25/2013 | US20130102766 Method and compositions for monitoring dna binding molecules in living cells |
| 04/25/2013 | US20130102497 Assay for drug discovery based on in vitro differentiated cells |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130102479 Methods of enhancing pluripotentcy |
| 04/25/2013 | US20130102076 Systems and methods for growing photosynthetic organisms |
| 04/25/2013 | US20130102074 Methods for reprogramming somatic cells |
| 04/25/2013 | US20130102073 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 04/25/2013 | US20130102032 Cell culture medium |
| 04/25/2013 | US20130102023 Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix |
| 04/25/2013 | US20130101982 Fluid mixing systems with adjustable mixing element |
| 04/25/2013 | US20130101981 Particle matrix for storage of biomolecules |
| 04/25/2013 | US20130101639 Bone semi-permeable device |
| 04/25/2013 | US20130101638 Bone semi-permeable device |
| 04/25/2013 | US20130101637 Bone Semi-Permeable Device |
| 04/25/2013 | US20130101635 Method of preparing self-assembled extracellular matrices and use of self-assembled extracellular matrices formed by using the method |
| 04/25/2013 | US20130101620 Recombinant varicella-zoster virus |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101577 Extended Soluble PH20 Polypeptides and uses thereof |
| 04/25/2013 | US20130101568 Il-13 producing tr1-like cells and use thereof |
| 04/25/2013 | US20130101567 Methods to Expand a T Regulatory Cell Master Cell Bank |
| 04/25/2013 | US20130101565 Use of carbonic anhydrase ii for producing a drug |
| 04/25/2013 | US20130101564 Method for preparing dermis tissue cells aggregation and uses thereof |
| 04/25/2013 | US20130101561 Closed system separation of adherent bone marrow stem cells for regenerative medicine applications |
| 04/25/2013 | CA2852950A1 Layered microfluidic living cell array |
| 04/25/2013 | CA2852672A1 Intracellular delivery |
| 04/25/2013 | CA2852244A1 Media for stem cell proliferation and induction |
| 04/25/2013 | CA2852021A1 Addition of iron to improve cell culture |
| 04/25/2013 | CA2851795A1 Anti-cd22 chimeric antigen receptors |
| 04/24/2013 | EP2584043A2 Anti-glypican 3 antibody having improved kinetics in plasma |
| 04/24/2013 | EP2584034A1 Pluripotent stem cell differentiation by using human feeder cells |
| 04/24/2013 | EP2584033A1 Genes and uses for plant improvement |
| 04/24/2013 | EP2584029A1 Sheet-shaped cell culture dissociation system |
| 04/24/2013 | EP2583976A2 Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens |
| 04/24/2013 | EP2583693A1 Pharmaceutical composition utilizing pancreatic cell proliferation factor |
| 04/24/2013 | EP2582847A2 Methods and materials for assessing loss of heterozygosity |
| 04/24/2013 | EP2582796A2 Modified parvovirus having enhanced anti-tumour efficacy |
| 04/24/2013 | EP2582795A1 Method for selecting human induced pluripotent stem cells |
| 04/24/2013 | EP2582794A2 Generation of induced pluripotent stem cells from small volumes of peripheral blood |
| 04/24/2013 | EP2582793A2 A compendium of ready-built stem cell models for interrogation of biological response |
| 04/24/2013 | EP2582792A2 Cardiomyocyte medium with dialyzed serum |
| 04/24/2013 | EP2582791A2 Hair follicle neogenesis |
| 04/24/2013 | EP2582790A2 Human blood-brain endothelial cells derived from pluripotent stem cells and blood-brain barrier model thereof |